Virus filtration is widely used to assure the viral safety of biopharmaceutical products. It is a size-based removal method which uses the polymeric membrane to retain virus particles on the surface and within the pores of the membrane. Virus filtration also helps to optimize process economics and prevents the loss of valuable products.    

Market Dynamics:

Rise in prevalence of chronic disease, rise in demand for biologics, increasing adoption of single-use technologies, rise in drug development, and the outbreak of COVID-19 (global pandemic) are major factors expected to propel growth of the global virus filtration market. For instance, in July 2022, Pall Corporation supplied the filtration solution for EverGrain’s new large-scale plant-based protein facility in St. Louis, Missouri. The new facility focuses on upcycling brewer’s saved grains with Pall Membralox Microfiltration System, which uses membranes with gradient permeability to purify the valuable protein. A purified high-functional protein, previously used for animal feed, can now be converted into nutritious, plant-friendly ingredients for other food products.

Key features of the study:

• This report provides in-depth analysis of the global virus filtration market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global virus filtration market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Wuxi Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck KgaA, Lonza Group Ltd., General Electric Company, Thermo Fischer Scientific Inc., Asahi Kasei Medical Co. Ltd., and Charles River Laboratories International Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global virus filtration market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virus filtration market.

Detailed Segmentation:

• Global Virus Filtration Market, By Product:
  • Kits and Reagents
  • Filtration Systems
  • Services
  • Other Products
• Global Virus Filtration Market, By Application:
  • Biologicals
  • Medical Devices
  • Water Purification
  • Air Purification
• Global Virus Filtration Market, By End User:
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organisations (CROs)
  • Academic Research Organisations
  • Medical Device Companies
• Global Virus Filtration Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Wuxi Biologics
  • Clean Cell Inc.
  • Sartorius AG
  • Pall Corporation
  • Merck KgaA
  • Lonza Group Ltd.
  • General Electric Company
  • Thermo Fischer Scientific Inc.
  • Asahi Kasei Medical Co. Ltd.
  • Charles River Laboratories International Inc.